NCT03397706 · Interventional trial
Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies
Overall registry status Completed
Phase 1 · Phase 2
Conditions Epstein-Barr Virus-Associated Lymphoma, Lymphoproliferative Disorders
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory